1291 / 1708
Conclusion
•
Proton therapy offers a CHANCE
for improved sparing of
normal tissue (or dose intensification)
•
Aim to
reduce adverse events and SMN
(less often for
intensification in the pediatric cohorts)
•
Increasing role in children
worldwide
•
Growing experiences in
CNS tumours and others
•
Advantage greater
for large target volumes, in high doses
and in very young
•
To be implemented into
multidisciplinary framework/trials
(SIOP, GPOH…)
•
At WPE/Essen particular focus on children
•
Increasing capacity
in Europe
•
Data
on PT (as on any other technique!) to be collected and
evaluated (toxicity/TU but also QoL & neuropsych.)
•
Education & training extremely important